AI assistant
Revenio Group Oyj — Director's Dealing 2024
Aug 14, 2024
3236_dirs_2024-08-14_1bf91d76-401a-4ce5-aea4-c85a13fee6f8.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Revenio Group Corporation: Managers' Transactions – Kate Taylor
Revenio Group Corporation | Stock Exchange Release | August 14, 2024 at 16:00:00 EEST
Person subject to the notification requirement Name: Kate Taylor Position: Other senior manager
Issuer: Revenio Group Oyj LEI: 743700I27E0FWSXLKK04 Notification type: INITIAL NOTIFICATION Reference number: 74370/5/4
Transaction date: 2024-08-13 Outside a trading venue Instrument type: SHARE ISIN: FI0009010912 Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE
Transaction details (1): Volume: 333 Unit price: 0 EUR
Aggregated transactions (1): Volume: 333 Volume weighted average price: 0 EUR
For further information, please contact
CFO Robin Pulkkinen, tel. +358 50 505 9932 [email protected]
Distribution Nasdaq Helsinki FIN-FSA Key media www.reveniogroup.fi/en
Revenio Group in brief
Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio's ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand.
In 2023, the Group's net sales totaled EUR 96.6 million, with an operating profit of EUR 26.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.
Attachments
Revenio Group Corporation: Managers' Transactions – Kate Taylor